MolNFT v1 · #139029 · protein
Crystal structure of human serine racemase
5X2L: “Crystal structure of human serine racemase”. X-ray diffraction, 2 ligands (PLP, MG), 2 pockets (best druggability 0.66). MolNFT v1 #139029 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5X2L
- Type
- protein
- Length
- 612 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Serine racemase
- EC
- 5.1.1.18, 4.3.1.18, 4.3.1.17
- UniProt
- Q9GZT4
- Ligands
- PLP, MG
- Pockets
- 2 · best druggability 0.66
Structure
x-ray diffraction · 2 distinct chains · 50% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Serine racemase (EC 5.1.1.18, 4.3.1.18, 4.3.1.17) | protein | 305 | 50% helix, 16% strand | Q9GZT4 |
| B | Serine racemase (EC 5.1.1.18, 4.3.1.18, 4.3.1.17) | protein | 307 | 50% helix, 16% strand | Q9GZT4 |
Ligands and binding sites
- PLP · Pyridoxal-5'-phosphate · ligand · 2 copies · chains A, B
- MG · Magnesium ion · metal · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 585 | 0.66 | 0.76 | 69 | PLP |
| 2 | 539 | 0.65 | 0.76 | 63 | PLP |
Interfaces
1 interface between chains.
- A–B · 200 Ų buried · 0 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 cofactor (pyridoxal phosphate Schiff base).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9GZT4
- Elsewhere: RCSB PDB 5X2L · PDBe 5X2L · UniProt Q9GZT4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.